Skip to contents

  1. Stilgenbauer, Stephan; Zenz, Thorsten; Winkler, Dirk; Bühler, Andreas; Schlenk, Richard F.; Groner, Silja; Busch, Raymonde; Hensel, Manfred; Dührsen, Ulrich; Finke, Jürgen; Dreger, Peter; Jäger, Ulrich; Lengfelder, Eva; Hohloch, Karin; Söling, Ulrike; Schlag, Rudolf; Kneba, Michael; Hallek, Michael; Döhner, Hartmut

    Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocytic Leukemia Study Group

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2009

    Published in: Journal of Clinical Oncology, 27 (2009) 24, Seite 3994-4001

  2. Germing, Ulrich; Lauseker, Michael; Hildebrandt, Barbara; Symeonidis, Argiris; Cermak, Jaroslav; Pfeilstöcker, Michael; Nösslinger, Thomas; Sekeres, Mikkael A.; Maciejewski, Jaroslaw P.; Haase, Detlef; Schanz, Julie; Seymour, Jf; Weide, Rudolf; Lübbert, Michael; Platzbecker, Uwe; Valent, Peter; Götze, Katharina; Stauder, Reinhard; Blum, Sabine; Kreuzer, Karl Anton; Schlenk, Richard F.; Aul, Carlo; Kündgen, Andrea; Hasford, Joerg;

    Survival, Prognostic Factors, and Rates of Leukemic Transformation in a Multicenter Study of 303 Untreated Patients with MDS and Del(5q)

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Hematology, 2009

    Published in: Blood, 114 (2009) 22, Seite 945-945